Vermont Tech Scene
SEE OTHER BRANDS

Exploring the science and technology news of Vermont

Vermont Tech Scene: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vermont Tech Scene.

Press releases published on April 30, 2025

Lantheus Announces Alzheimer’s Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies

Lantheus Announces Alzheimer’s Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies

BEDFORD, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, …

Kiniksa Pharmaceuticals Announces GRAMMY® Award-Winning Country Star, Carly Pearce, Joins the Life DisRPted™ Campaign, Adding to Voices Advocating for Awareness of Recurrent Pericarditis

Kiniksa Pharmaceuticals Announces GRAMMY® Award-Winning Country Star, Carly Pearce, Joins the Life DisRPted™ Campaign, Adding to Voices Advocating for Awareness of Recurrent Pericarditis

– Pearce joins NHL Hall-of-Famer, Henrik Lundqvist, to educate patients and caregivers about the importance of accurate and early diagnosis of recurrent pericarditis, a chronic autoinflammatory disease of the heart that is often underdiagnosed or …

Rakovina Therapeutics Inc. Announces 2024 Financial Results and Provides Corporate Update

Rakovina Therapeutics Inc. Announces 2024 Financial Results and Provides Corporate Update

VANCOUVER, British Columbia, April 30, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered drug discovery announced …

Oncocyte Provides Positive Update on Clinical Trial Progress

Oncocyte Provides Positive Update on Clinical Trial Progress

Central Institutional Review Board approved, final preparatory steps underway at first transplant centers Three of the top 10 U.S. transplant centers expected to participate in trial Nearly 10% of annual U.S. transplant volume represented in trial site …

Jet.AI and Consensus Core Announce Plans for Multi-Billion Dollar (1.5 GW) AI Data Center Joint Venture in Canada

Jet.AI and Consensus Core Announce Plans for Multi-Billion Dollar (1.5 GW) AI Data Center Joint Venture in Canada

LAS VEGAS, April 30, 2025 (GLOBE NEWSWIRE) -- Jet.AI Inc. (“Jet.AI” or the “Company”) (Nasdaq: JTAI), a company transitioning to a pure-play artificial-intelligence (“AI”) data-center enterprise, announced the signing of a Letter of Intent (“LOI”) to form …

SAIC and Bluescape Announce Strategic Partnership to Deliver Secure, Mission-Critical Operations Platform

SAIC and Bluescape Announce Strategic Partnership to Deliver Secure, Mission-Critical Operations Platform

RESTON, Va., April 30, 2025 (GLOBE NEWSWIRE) -- Science Applications International Corp. (NASDAQ: SAIC) – a mission integrator for delivering advanced technology solutions to the government – announced today that it has established a strategic partnership …

Polyrix Unveils Groundbreaking Inline Metrology System at Control 2025

Polyrix Unveils Groundbreaking Inline Metrology System at Control 2025

SAINT-AUGUSTIN, Quebec, April 30, 2025 (GLOBE NEWSWIRE) -- Polyrix, a leader in cutting-edge metrology imaging, proudly announces the launch of the first-ever PolyScan V inline system capable of scanning a full part in 20-seconds, to be debuted at the …

CERo Therapeutics Holdings, Inc. Announces TriStar Centennial Medical Center as a Clinical Trial Site for its Phase 1 Clinical Trial of CER-1236 in Acute Myeloid Leukemia

CERo Therapeutics Holdings, Inc. Announces TriStar Centennial Medical Center as a Clinical Trial Site for its Phase 1 Clinical Trial of CER-1236 in Acute Myeloid Leukemia

SOUTH SAN FRANCISCO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that …

Sagtec Global Limited Achieves Strong Fiscal Year 2024 Performance with US$11.6 Million Revenue, Marking 78% Year-over-Year Growth

Sagtec Global Limited Achieves Strong Fiscal Year 2024 Performance with US$11.6 Million Revenue, Marking 78% Year-over-Year Growth

KUALA LUMPUR, Malaysia, April 30, 2025 (GLOBE NEWSWIRE) -- Sagtec Global Limited (NASDAQ: SAGT) (“Sagtec” or the “Company”), a leading provider of customizable software solutions, today announced its audited financial results for the financial year ended …

Genius Group Announces 2024 Financial Results, 303% NAV Growth

Genius Group Announces 2024 Financial Results, 303% NAV Growth

Increase in Net Asset Value (NAV) to $79.4 million from $19.7 million in 2023. SINGAPORE, April 30, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group,  …

Kneat to Announce 2025 First-Quarter Financial Results May 7, 2025

Kneat to Announce 2025 First-Quarter Financial Results May 7, 2025

LIMERICK, Ireland, April 30, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTC: KSIOF) (“Kneat” or the “Company”) a leader in digitizing and automating validation and quality processes, announced today that the Company will release its financial …

Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study

Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study

— Successfully demonstrates strong tolerability, sustained drug release and safety SARASOTA, FL, April 30, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo,” or the “Company”), a developmental stage biopharmaceutical company focused on …

Cellectar Announces Plan to Explore Strategic Alternatives

Cellectar Announces Plan to Explore Strategic Alternatives

FLORHAM PARK, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today …

Catalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025

Catalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025

CORAL GABLES, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for …

Voxtur Announces Financial Results for the Year and Quarter Ended December 31, 2024

Voxtur Announces Financial Results for the Year and Quarter Ended December 31, 2024

TORONTO and TAMPA, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- Voxtur Analytics Corp. (TSXV: VXTR; OTCQB: VXTRF) ("Voxtur" or the "Company"), a North American technology company creating a more transparent and accessible real estate lending ecosystem, today …

BioAtla to Participate in the Citizens Life Sciences Conference

BioAtla to Participate in the Citizens Life Sciences Conference

SAN DIEGO, April 30, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today …

EDR Killers: What They Are, Why They Matter, and How Organizations Can Stay Protected

EDR Killers: What They Are, Why They Matter, and How Organizations Can Stay Protected

SAN DIEGO, April 30, 2025 (GLOBE NEWSWIRE) -- ESET, a global leader in cybersecurity, is warning organizations to stay alert as “EDR killers” - tools designed to disable Endpoint Detection and Response (EDR) solutions- grow more accessible and more widely …

StarTree Unveils AI-Native Real-Time Analytics and Launches Bring Your Own Kubernetes (BYOK) to Power the Next Generation of Enterprise Intelligence

StarTree Unveils AI-Native Real-Time Analytics and Launches Bring Your Own Kubernetes (BYOK) to Power the Next Generation of Enterprise Intelligence

MOUNTAIN VIEW, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- StarTree, the cloud-based real-time analytics company, today announced two new powerful AI-native innovations to its real-time data platform for enterprise workloads: Model Context Protocol (MCP) …

Snyk Joins Coalition for Secure AI (CoSAI) to Champion Safe, Responsible AI Development

Snyk Joins Coalition for Secure AI (CoSAI) to Champion Safe, Responsible AI Development

Coalition signals Snyk’s commitment to advancing industry-wide collaboration around Secure-by-Design AI systems BOSTON, April 30, 2025 (GLOBE NEWSWIRE) -- Snyk, a leader in developer security, today announced it has joined the Coalition for Secure AI ( …

Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2025 Financial Results on May 7

Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2025 Financial Results on May 7

DUBLIN, Ireland, April 30, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 8:00 a. …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service